The DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index.
Neurodegenerative disorders: Mechanisms of degeneration and therapeutic approaches with their clinical relevance
Open accessAbstract
Neurodegenerative disorders (NDs) are expected to pose a significant challenge for both medicine and public health in the upcoming years due to global demographic changes. NDs are mainly represented by degeneration/loss of neurons, which is primarily accountable for severe mental illness. This neuronal degeneration leads to many neuropsychiatric problems and permanent disability in an individual. Moreover, the tight junction of the brain, blood-brain barrier (BBB)has a protective feature, functioning as a biological barrier that can prevent medicines, toxins, and foreign substances from entering the brain. However, delivering any medicinal agent to the brain in NDs (i.e., Multiple sclerosis, Alzheimer's, Parkinson's, etc.) is enormously challenging. There are many approved therapies to address NDs, but most of them only help treat the associated manifestations. The available therapies have failed to control the progression of NDs due to certain factors, i.e., BBB and drug-associated undesirable effects. NDs have extremely complex pathology, with many pathogenic mechanisms involved in the initiation and progression; thereby, a limited survival rate has been observed in ND patients. Hence, understanding the exact mechanism behind NDs is crucial to developing alternative approaches for improving ND patients' survival rates. Thus, the present review sheds light on different cellular mechanisms involved in NDs and novel therapeutic approaches with their clinical relevance, which will assist researchers in developing alternate strategies to address the limitations of conventional ND therapies. The current work offers the scope into the near future to improve the therapeutic approach of NDs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Gadhave, D. G., Tagalpallewar, A. A., & Kokare, C. (2019) · AAPS PharmSciTech · doi:10.1208/s12249-018-1213-y · Cited by 50
Self-citationRetractedGadhave, D. G., Choudhury, H., & Kokare, C. (2018) · Applied Nanoscience · doi:10.1007/s13204-018-0909-3 · Cited by 38
Self-citationRetractedMitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
Zorov, D. B., Juhaszova, M., & Sollott, S. J. (2014) · Physiological Reviews · doi:10.1152/physrev.00026.2013 · Cited by 5,383
Mitochondrial formation of reactive oxygen species
Turrens, J. F. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.049478 · Cited by 5,084
Juan, C. A., Pérez de la Lastra, J. M., Plou, F. J., & Pérez-Lebeña, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094642 · Cited by 2,810
Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
Breijyeh, Z., & Karaman, R. (2020) · Molecules · doi:10.3390/molecules25245789 · Cited by 2,789
Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes
Kwon, H. S., & Koh, S.-H. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-020-00221-2 · Cited by 2,595
Glial and neuronal control of brain blood flow
Attwell, D., Buchan, A. M., Charpak, S., Lauritzen, M., MacVicar, B. A., & Newman, E. A. (2010) · Nature · doi:10.1038/nature09613 · Cited by 2,511 · cited 1×
“These various cell types play crucial roles in BBB induction and preservation by controlling brain endothelial cell migration, proliferation, and vascular branching (Attwell et al., 2010).”
BackgroundOxidative Stress: A Key Modulator in Neurodegenerative Diseases
Singh, A., Kukreti, R., Saso, L., & Kukreti, S. (2019) · Molecules · doi:10.3390/molecules24081583 · Cited by 2,254
The blood–brain barrier and blood–tumour barrier in brain tumours and metastases
Arvanitis, C. D., Ferraro, G. B., & Jain, R. K. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0205-x · Cited by 1,792
Oxidative Stress, Synaptic Dysfunction, and Alzheimer’s Disease
Tönnies, E., & Trushina, E. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161088 · Cited by 1,750
Role of ROS and RNS Sources in Physiological and Pathological Conditions
Di Meo, S., Reed, T. T., Venditti, P., & Victor, V. M. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1245049 · Cited by 1,614
Yano, M., Katayose, Y., Ashikari, M., Yamanouchi, U., Monna, L., Fuse, T., Baba, T., Yamamoto, K., Umehara, Y., Nagamura, Y., et al. (2000) · The Plant Cell · doi:10.1105/tpc.12.12.2473 · Cited by 1,585
The Haber–Weiss reaction and mechanisms of toxicity
Kehrer, J. P. (2000) · Toxicology · doi:10.1016/s0300-483x(00)00231-6 · Cited by 1,418 · cited 1×
“The hydroxyl radical can also be made in the Haber-Weiss reaction (Kehrer, 2000).”
BackgroundOxidative Stress and the Central Nervous System
Salim, S. (2017) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.237503 · Cited by 1,247
Amyotrophic lateral sclerosis: a clinical review
Masrori, P., & Van Damme, P. (2020) · European Journal of Neurology · doi:10.1111/ene.14393 · Cited by 1,201
Wallin, M. T., Culpepper, W. J., Nichols, E., Bhutta, Z. A., Gebrehiwot, T. T., Hay, S. I., Khalil, I. A., Krohn, K. J., Liang, X., Naghavi, M., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30443-5 · Cited by 1,134
Neurobiological and Systemic Effects of Chronic Stress
McEwen, B. S. (2017) · Chronic Stress · doi:10.1177/2470547017692328 · Cited by 1,059 · cited 1×
“These gradually increase their intensity resulting in cell death (McEwen, 2017).”
BackgroundHuntington's disease: a clinical review
Roos, R. A. (2010) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-5-40 · Cited by 1,037
Saudou, F., & Humbert, S. (2016) · Neuron · doi:10.1016/j.neuron.2016.02.003 · Cited by 951
DeMaagd, G. A., & Philip, A. (2015) · PubMed · Cited by 926
Blood–brain Barrier: Structural Components and Function Under Physiologic and Pathologic Conditions
Persidsky, Y., Ramirez, S. H., Haorah, J., & Kanmogne, G. D. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-006-9025-3 · Cited by 922 · cited 1×
“Microglia are important for safeguarding CNS homeostasis and mediating immunological control in the brain (Persidsky et al., 2006; Saenz del Burgo et al., 2014).”
BackgroundLamptey, R. N. L., Chaulagain, B., Trivedi, R., Gothwal, A., Layek, B., & Singh, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031851 · Cited by 900
Oxidative Stress and Neurotoxicity
Sayre, L. M., Perry, G., & Smith, M. A. (2008) · Chemical Research in Toxicology · doi:10.1021/tx700210j · Cited by 867
Chemical Basis of Reactive Oxygen Species Reactivity and Involvement in Neurodegenerative Diseases
Collin, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102407 · Cited by 816
Role of reactive oxygen species in cell signalling pathways
Hancock, J. T., Desikan, R., & Neill, S. J. (2001) · Biochemical Society Transactions · doi:10.1042/0300-5127:0290345 · Cited by 806
Spreading of pathology in neurodegenerative diseases: a focus on human studies
Brettschneider, J., Tredici, K. D., Lee, V. M.-Y., & Trojanowski, J. Q. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3887 · Cited by 790
Evaluation of intranasal delivery route of drug administration for brain targeting
Erdő, F., Bors, L. A., Farkas, D., Bajza, Á., & Gizurarson, S. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.10.009 · Cited by 744
Ou, Z., Pan, J., Tang, S., Duan, D., Yu, D., Nong, H., & Wang, Z. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.776847 · Cited by 729
A comprehensive review of amyotrophic lateral sclerosis
Zarei, S., Carr, K., Reiley, L., Diaz, K., Guerra, O., Altamirano, P., Pagani, W., Lodin, D., Orozco, G., & Chinea, A. (2015) · Surgical Neurology International · doi:10.4103/2152-7806.169561 · Cited by 709
A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation
Goldmann, T., Wieghofer, P., Müller, P. F., Wolf, Y., Varol, D., Yona, S., Brendecke, S. M., Kierdorf, K., Staszewski, O., Datta, M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3531 · Cited by 688
Current and future treatments for Alzheimer's disease
Yiannopoulou, K. G., & Papageorgiou, S. G. (2013) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285612461679 · Cited by 677 · cited 2×
“Without a reproducible and informative model system of neurodegenerative disease (e.g., including multiple cell types in addition to mature neurons), the invention of novel therapeutic strategies will repeatedly stall (Yiannopoulou and Papageorgiou, 2013).”
BackgroundOxidative Stress and Antioxidants in Neurodegenerative Disorders
Olufunmilayo, E. O., Gerke-Duncan, M. B., & Holsinger, R. M. D. (2023) · Antioxidants · doi:10.3390/antiox12020517 · Cited by 670
Role of peroxisomes in ros/rns-metabolism: Implications for human disease
Fransen, M., Nordgren, M., Wang, B., & Apanasets, O. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.12.001 · Cited by 644
Basic mechanisms of neurodegeneration: a critical update
Jellinger, K. A. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01010.x · Cited by 596
Kivisäkk, P., Mahad, D. J., Callahan, M. K., Trebst, C., Tucky, B., Wei, T., Wu, L., Baekkevold, E. S., Lassmann, H., Staugaitis, S. M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1433000100 · Cited by 549
Alzheimer's disease: synaptic dysfunction and Aβ
Shankar, G. M., & Walsh, D. M. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-48 · Cited by 486
Projected increase in amyotrophic lateral sclerosis from 2015 to 2040
Arthur, K. C., Calvo, A., Price, T. R., Geiger, J. T., Chiò, A., & Traynor, B. J. (2016) · Nature Communications · doi:10.1038/ncomms12408 · Cited by 474
Farace, C., Melguizo, C., Asara, Y., Álvarez, P., Prados, J. C., Tolu, P., Delogu, G., Aránega, A., & Madeddu, R. (2011) · Cited by 464
Astrocytes and microglia: In sickness and in health
Vainchtein, I. D., & Molofsky, A. V. (2020) · Trends in Neurosciences · doi:10.1016/j.tins.2020.01.003 · Cited by 450
NADPH oxidase in brain injury and neurodegenerative disorders
Ma, M. W., Wang, J., Zhang, Q., Wang, R., Dhandapani, K. M., Vadlamudi, R. K., & Brann, D. W. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0150-7 · Cited by 432
Brain Energy and Oxygen Metabolism: Emerging Role in Normal Function and Disease
Watts, M. E., Pocock, R., & Claudianos, C. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00216 · Cited by 411
Tirichen, H., Yaigoub, H., Xu, W., Wu, C., Li, R., & Li, Y. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.627837 · Cited by 407
Clinical Course of Multiple Sclerosis
Klineova, S., & Lublin, F. D. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a028928 · Cited by 401
Jo, M., Lee, S., Jeon, Y.-M., Kim, S., Kwon, Y., & Kim, H.-J. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00513-7 · Cited by 397
The Role of NADPH Oxidases and Oxidative Stress in Neurodegenerative Disorders
Tarafdar, A., & Pula, G. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123824 · Cited by 373
Ex vivo gene transfer and correction for cell-based therapies
Naldini, L. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2985 · Cited by 358
Wang, Y.-X., Robertson, J. L., Spillman, W. B., & Claus, R. O. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000036909.41843.18 · Cited by 357
Castelpietra, G., Knudsen, A. K. S., Agardh, E. E., Armocida, B., Beghi, M., Iburg, K. M., Logroscino, G., Ma, R., Starace, F., Steel, N., et al. (2022) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2022.100341 · Cited by 347
Old Drugs as New Treatments for Neurodegenerative Diseases
Durães, F., Pinto, M., & Sousa, E. (2018) · Pharmaceuticals · doi:10.3390/ph11020044 · Cited by 343
Current approaches to the treatment of Parkinson’s disease
Jankovic, J. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s2006 · Cited by 342
A mitochondrial superoxide theory for oxidative stress diseases and aging
Indo, H. P., Yen, H.-C., Nakanishi, I., Matsumoto, K.-I., Tamura, M., Nagano, Y., Matsui, H., Gusev, O., Cornette, R., Okuda, T., et al. (2015) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.14-42 · Cited by 334
Solving neurodegeneration: common mechanisms and strategies for new treatments
Wareham, L. K., Liddelow, S. A., Temple, S., Benowitz, L. I., Di Polo, A., Wellington, C., Goldberg, J. L., He, Z., Duan, X., Bu, G., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00524-0 · Cited by 324
IFN-γ-dependent activation of the brain’s choroid plexus for CNS immune surveillance and repair
Kunis, G., Baruch, K., Rosenzweig, N., Kertser, A., Miller, O., Berkutzki, T., & Schwartz, M. (2013) · Brain · doi:10.1093/brain/awt259 · Cited by 321
Schulte, J., & Littleton, J. T. (2011) · PubMed · Cited by 314
Role of Amyloid-β and Tau Proteins in Alzheimer’s Disease: Confuting the Amyloid Cascade
Gulisano, W., Maugeri, D., Baltrons, M. A., Fà, M., Amato, A., Palmeri, A., D’Adamio, L., Grassi, C., Devanand, D. P., Honig, L. S., et al. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-179935 · Cited by 313 · cited 1×
“3 B) (Gulisano et al., 2018).”
Ding, C., Wu, Y., Chen, X., Chen, Y., Wu, Z., Lin, Z., Kang, D., Fang, W., & Chen, F. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.952161 · Cited by 311
Mitochondria: It is all about energy
Casanova, A., Wevers, A., Navarro-Ledesma, S., & Pruimboom, L. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1114231 · Cited by 303
Jankovic, J., Goodman, I., Safirstein, B., Marmon, T. K., Schenk, D. B., Koller, M., Zago, W., Ness, D. K., Griffith, S. G., Grundman, M., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.1487 · Cited by 301
Multiple Sclerosis: Immunopathology and Treatment Update
Dargahi, N., Katsara, M., Tselios, T., Androutsou, M.-E., De Courten, M., Matsoukas, J., & Apostolopoulos, V. (2017) · Brain Sciences · doi:10.3390/brainsci7070078 · Cited by 285
Mitochondrial Management of Reactive Oxygen Species
Napolitano, G., Fasciolo, G., & Venditti, P. (2021) · Antioxidants · doi:10.3390/antiox10111824 · Cited by 281
New Insights on NOX Enzymes in the Central Nervous System
Nayernia, Z., Jaquet, V., & Krause, K.-H. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5703 · Cited by 279
Quantitative imaging of energy expenditure in human brain
Zhu, X.-H., Qiao, H., Du, F., Xiong, Q., Liu, X., Zhang, X., Ugurbil, K., & Chen, W. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.02.013 · Cited by 265
Advances in therapeutic CRISPR/Cas9 genome editing
Savić, N., & Schwank, G. (2016) · Translational Research · doi:10.1016/j.trsl.2015.09.008 · Cited by 257
Active and passive immunotherapy for neurodegenerative disorders
Brody, D. L., & Holtzman, D. M. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.31.060407.125529 · Cited by 250 · cited 1×
“Early-stage human trials related to active amyloid beta vaccination were prematurely halted due to safety concerns (Brody and Holtzman, 2008).”
BackgroundNeuroinflammation: Ways in Which the Immune System Affects the Brain
Ransohoff, R. M., Schafer, D., Vincent, A., Blachère, N. E., & Bar-Or, A. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0385-3 · Cited by 243
Protein misfolding and aggregation in Alzheimer’s disease and type 2 diabetes mellitus
Ashraf, G., Greig, N., Khan, T., Hassan, I., Tabrez, S., Shakil, S., Sheikh, I., Zaidi, S., Akram, M., Jabir, N., et al. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666140917095514 · Cited by 236
The Role of Mitochondria in Inflammation: From Cancer to Neurodegenerative Disorders
Missiroli, S., Genovese, I., Perrone, M., Vezzani, B., Vitto, V. A. M., & Giorgi, C. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9030740 · Cited by 234
Pathomechanisms of TDP‐43 in neurodegeneration
Gao, J., Wang, L., Huntley, M. L., Perry, G., & Wang, X. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14327 · Cited by 228
Tanaka, M., Toldi, J., & Vécsei, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072431 · Cited by 222
Oxidative Stress in the Brain: Basic Concepts and Treatment Strategies in Stroke
Jelinek, M., Jurajda, M., & Duris, K. (2021) · Antioxidants · doi:10.3390/antiox10121886 · Cited by 215
Huang, Y., Li, Y., Pan, H., & Han, L. (2023) · Journal of Global Health · doi:10.7189/jogh.13.04160 · Cited by 199
AAV-based in vivo gene therapy for neurological disorders
Ling, Q., Herstine, J. A., Bradbury, A., & Gray, S. J. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00766-7 · Cited by 197
Weihofen, A., Liu, Y., Arndt, J. W., Huy, C., Quan, C., Smith, B. A., Baeriswyl, J.-L., Cavegn, N., Senn, L., Su, L., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.10.016 · Cited by 195
Gene therapy for neurodegenerative disorders: advances, insights and prospects
Chen, W., Hu, Y., & Ju, D. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.01.015 · Cited by 187
Amyotrophic lateral sclerosis: improving care with a multidisciplinary approach
Hogden, A., Foley, G., Henderson, R., James, N., & Aoun, S. (2017) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s134992 · Cited by 185
Jiménez-Balado, J., & Eich, T. S. (2021) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2021.01.005 · Cited by 183
A brief overview of amyloids and Alzheimer's disease
Ow, S., & Dunstan, D. E. (2014) · Protein Science · doi:10.1002/pro.2524 · Cited by 175
Non-Invasive Drug Delivery across the Blood–Brain Barrier: A Prospective Analysis
Niazi, S. K. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15112599 · Cited by 168
Hogan, D. B., Bailey, P., Black, S., Carswell, A., Chertkow, H., Clarke, B., Cohen, C., Fisk, J. D., Forbes, D., Man-Son-Hing, M., et al. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.081103 · Cited by 167 · cited 3×
“PD often results from the gradual deterioration of neurons that produce dopamine in the brain, particularly in a region called the substantia nigra (Hogan et al., 2008).”
BackgroundNeuroinflammation: A Potential Risk for Dementia
Ahmad, M. A., Kareem, O., Khushtar, M., Akbar, M., Haque, M. R., Iqubal, A., Haider, M. F., Pottoo, F. H., Abdulla, F. S., Al-Haidar, M. B., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020616 · Cited by 160
Clinical and Imaging Markers of Prodromal Parkinson's Disease
Hustad, E., & Aasly, J. O. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00395 · Cited by 147
Trends in the Molecular Pathogenesis and Clinical Therapeutics of Common Neurodegenerative Disorders
Choonara, Y. E., Pillay, V., du Toit, L. C., Modi, G., Naidoo, D., Ndesendo, V. M. K., & Sibambo, S. R. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10062510 · Cited by 135
Immunotherapy for neurodegenerative diseases: Focus on α-synucleinopathies
Valera, E., & Masliah, E. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.013 · Cited by 132
Protein Misfolding and Aggregation in Proteinopathies: Causes, Mechanism and Cellular Response
Ajmal, M. R. (2023) · Diseases · doi:10.3390/diseases11010030 · Cited by 131
Clinical Gene Therapy for Neurodegenerative Diseases: Past, Present, and Future
Piguet, F., Alves, S., & Cartier, N. (2017) · Human Gene Therapy · doi:10.1089/hum.2017.160 · Cited by 127
Microglia in Aging and Alzheimer’s Disease: A Comparative Species Review
Edler, M. K., Mhatre-Winters, I., & Richardson, J. R. (2021) · Cells · doi:10.3390/cells10051138 · Cited by 126
Nanotherapeutic approaches for brain cancer management
del Burgo, L. S., Hernández, R. M., Orive, G., & Pedraz, J. L. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.10.001 · Cited by 125
Gadhave, D. G., & Kokare, C. (2019) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2019.1576724 · Cited by 125
Self-citationImmunotherapies for Neurodegenerative Diseases
Mortada, I., Farah, R., Nabha, S. M., Ojcius, D. M., Fares, Y., Almawi, W. Y., & Sadier, N. S. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.654739 · Cited by 122
Neurodegenerative diseases linked to misfolded proteins and their therapeutic approaches: A review
Khanam, H., Ali, A., Asif, M., & Shamsuzzaman (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.08.006 · Cited by 108
Biomaterials in Neurodegenerative Disorders: A Promising Therapeutic Approach
Bordoni, M., Scarian, E., Rey, F., Gagliardi, S., Carelli, S., Pansarasa, O., & Cereda, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093243 · Cited by 103
The CD40–CD40L Dyad in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
Aarts, S. A. B. M., Seijkens, T. T. P., van Dorst, K. J. F., Dijkstra, C. D., Kooij, G., & Lutgens, E. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01791 · Cited by 95
Anxiety: An ignored aspect of Parkinson’s disease lacking attention
Khatri, D. K., Choudhary, M., Sood, A., & Singh, S. B. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110776 · Cited by 94
Self-citationSwerdlow, R. H. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.01.008 · Cited by 91
Medical Management of Parkinson’s Disease
Encarnacion, E. V., & Hauser, R. A. (2009) · Springer eBooks · doi:10.1007/978-3-540-69960-6_90 · Cited by 89
Ex vivo gene therapy for the treatment of neurological disorders
Gowing, G., Svendsen, S. P., & Svendsen, C. N. (2017) · Progress in brain research · doi:10.1016/bs.pbr.2016.11.003 · Cited by 88
Neuro-nanotechnology: diagnostic and therapeutic nano-based strategies in applied neuroscience
Shabani, L., Abbasi, M., Azarnew, Z., Amani, A. M., & Vaez, A. (2023) · BioMedical Engineering OnLine · doi:10.1186/s12938-022-01062-y · Cited by 86
The Differential Diagnosis of Parkinson’s Disease
Greenland, J. C., & Barker, R. A. (2018) · Codon Publications eBooks · doi:10.15586/codonpublications.parkinsonsdisease.2018.ch6 · Cited by 80
Redox‐Responsive Nanobiomaterials‐Based Therapeutics for Neurodegenerative Diseases
Eleftheriadou, D., Kesidou, D., Moura, F., Felli, É., & Song, W. (2020) · Small · doi:10.1002/smll.201907308 · Cited by 78
Dopamine Function and the Efficiency of Human Movement
Gepshtein, S., Li, X., Snider, J., Plank, M., Lee, D., & Poizner, H. (2013) · Journal of Cognitive Neuroscience · doi:10.1162/jocn_a_00503 · Cited by 77
CRISPR/Cas9 genome editing for neurodegenerative diseases
Nojadeh, J. N., Eryilmaz, N. S. B., & Ergüder, B. İ. (2023) · EXCLI journal · doi:10.17179/excli2023-6155 · Cited by 75
Gadhave, D. G., Tupe, S., Tagalpallewar, A. A., Gorain, B., Choudhury, H., & Kokare, C. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121050 · Cited by 68
Self-citationZhu, X., Lu, M., & Chen, W. (2018) · Journal of Magnetic Resonance · doi:10.1016/j.jmr.2018.05.005 · Cited by 64
Microglia as therapeutic target in central nervous system disorders
Fatoba, O., Itokazu, T., & Yamashita, T. (2020) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2020.07.004 · Cited by 61
Perspectives on molecular targeted therapies and clinical trials for neurodegenerative diseases
Katsuno, M., Tanaka, F., & Sobue, G. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301307 · Cited by 60
Kumar, A., Zhou, L., Zhi, K., Raji, B., Pernell, S., Tadrous, E., Kodidela, S., Nookala, A. R., Kochat, H., & Kumar, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010138 · Cited by 56
Eva, L., Pleș, H., Covache-Busuioc, R.-A., Glavan, L.-A., Bratu, B.-G., Bordeianu, A., Dumitrascu, D.-I., Corlatescu, A.-D., & Ciurea, A. V. (2023) · Biomedicines · doi:10.3390/biomedicines11092489 · Cited by 55
Huntington's Disease, Huntington's Disease Look‐Alikes, and Benign Hereditary Chorea: What's New?
Schneider, S. A., & Bird, T. D. (2016) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12312 · Cited by 54
Parkinson’s Disease: Cognitive Impairment
Mack, J., & Marsh, L. (2017) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20160043 · Cited by 54
Biomaterials Evaluation: Conceptual Refinements and Practical Reforms
Masaeli, R., Zandsalimi, K., & Tayebi, L. (2018) · Therapeutic Innovation & Regulatory Science · doi:10.1177/2168479018774320 · Cited by 49
Amyotrophic Lateral Sclerosis Mortality in the United States, 2011–2014
Larson, T. C., III, Kaye, W., Mehta, P., & Horton, D. K. (2018) · Neuroepidemiology · doi:10.1159/000488891 · Cited by 48
Engineered exosomes for cancer theranostics: Next-generation tumor targeting
Chavda, V. P., Sugandhi, V. V., Pardeshi, C. V., Patil, R., Joshi, M., Patel, B. M., Khadela, A. D., Bezbaruah, R., Bhattacharjee, B., Balar, P. C., et al. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104579 · Cited by 48
Self-citationHuang, P., & Zhang, M. (2022) · Neuroscience Bulletin · doi:10.1007/s12264-022-00905-x · Cited by 47
Emerging therapeutic developments in neurodegenerative diseases: A clinical investigation
Kumar, D., Ashraf, G. M., Bilgrami, A. L., & Hassan, M. I. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.06.005 · Cited by 42
Novel Biomaterials for Tissue Engineering 2018
Stratakis, E. I. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123960 · Cited by 39
Imran, M., Insaf, A., Hasan, N., Sugandhi, V. V., Shrestha, D., Paudel, K. R., Jha, S. K., Hansbro, P. M., Dua, K., Devkota, H. P., et al. (2023) · Molecules · doi:10.3390/molecules28083475 · Cited by 39
Self-citationPharmacokinetics of vitamin dosage forms: A complete overview
Sugandhi, V. V., Pangeni, R., Vora, L. K., Poudel, S., Nangare, S., Jagwani, S., Gadhave, D. G., Qin, C., Pandya, A., Shah, P., et al. (2023) · Food Science & Nutrition · doi:10.1002/fsn3.3787 · Cited by 39
Self-citationModulation of the blood-tumor barrier to enhance drug delivery and efficacy for brain metastases
Blethen, K. E., Arsiwala, T. A., Fladeland, R. A., Sprowls, S. A., Panchal, D. M., Adkins, C. E., Kielkowski, B. N., Earp, L., Glass, M. J., Pritt, T. A., et al. (2021) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdab123 · Cited by 36
Gadhave, D. G., Sugandhi, V. V., & Kokare, C. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148674 · Cited by 35
Self-citationNanomedicine-based immunotherapy for Alzheimer's disease
Hoque, M., Samanta, A., Alam, S. S. M., Zughaibi, T. A., Kamal, M. A., & Tabrez, S. S. M. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104973 · Cited by 34
Challenges in neurodegeneration research
Noble, W. J. (2010) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2010.00007 · Cited by 33
Immunotherapy Targeting Neurodegenerative Proteinopathies: α-Synucleinopathies and Tauopathies
Shin, J. H., Kim, H., & Jeon, B. (2019) · Journal of Movement Disorders · doi:10.14802/jmd.19057 · Cited by 32
Pyrimidine analogues for the management of neurodegenerative diseases
Pant, S., Kapri, A., & Nain, S. (2022) · European Journal of Medicinal Chemistry Reports · doi:10.1016/j.ejmcr.2022.100095 · Cited by 32
Mitochondrial quality control in the brain: The physiological and pathological roles
Shen, X., Sun, P., Zhang, H., & Yang, H. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1075141 · Cited by 31
Neupane, P., Thada, P. K., Singh, P., Faisal, A. R., Rai, N., Poudel, P., Waleed, M. S., Quinonez, J., Ruxmohan, S., & Jain, E. (2023) · Cureus · doi:10.7759/cureus.33746 · Cited by 31
Gadhave, D., Gupta, A., Khot, S., Tagalpallewar, A., & Kokare, C. (2023) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2022.08.010 · Cited by 29
Self-citationNeuroimaging Advances in Neurologic and Neurodegenerative Diseases
Risacher, S. L., & Saykin, A. J. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01105-7 · Cited by 26
Soluble Megalin is Reduced in Cerebrospinal Fluid Samples of Alzheimer’s Disease Patients
Spuch, C., Antequera, D., Pascual, C., Abilleira, S., Blanco, M., Moreno-Carretero, M. J., Romero-López, J., Ishida, T., Molina, J. A., Villarejo‐Galende, A., et al. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00134 · Cited by 24
The Role of Interferon- α in Neurodegenerative Diseases: A Systematic Review
Hui, B. S. M., Zhi, L. R., Retinasamy, T., Arulsamy, A., Law, C. S. W., Shaikh, M. F., & Yeong, K. Y. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221081 · Cited by 22
Exploring the Role of Gene Therapy for Neurological Disorders
Puranik, N., Yadav, D., Chauhan, P., Kwak, M., & Jin, J. (2020) · Current Gene Therapy · doi:10.2174/1566523220999200917114101 · Cited by 20
Triantafyllakou, I., Clemente, N., Khetavat, R. K., Dianzani, U., & Tselios, T. V. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00277 · Cited by 20
Newer therapies for multiple sclerosis
Coles, A. J. (2015) · Annals of Indian Academy of Neurology · doi:10.4103/0972-2327.164824 · Cited by 17
Differential diagnosis of Parkinson’s disease
AGNOLI, A., Stocchi, F., & Carta, A. (1990) · New vistas in drug research · doi:10.1007/978-3-7091-9098-2_3 · Cited by 6
Cited by
Tanaka, M., Battaglia, S., & Liloia, D. (2025) · Biomedicines · doi:10.3390/biomedicines13051045 · Cited by 24
Metadata
- Authors
- Gadhave, D. G., Sugandhi, V. V., Jha, S. K., Nangare, S. N., Gupta, G., Singh, S. K., Dua, K., Cho, H., Hansbro, P. M., & Paudel, K. R.
- Venue
- Ageing Research Reviews
- Publisher
- Elsevier BV
- Published
- 2024-08
- Volume
- 99
- Pages
- 102357
- ISSN
- 1568-1637 (ISSN-L)
- OpenAlex
- W4399258275
- Cited by
- 358
- References
- 134
- FWCI
- 27.44
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.